Most people with MS who are treated with formulations of botulinum toxin to manage spasticity report being satisfied, a study ...

The cannabinoid agonist market is gaining momentum due to expanding medical cannabis legalization and growing clinical validation for its use in chronic pain, epilepsy, and inflammatory conditions.

Synthetic cannabinoids, a class of new psychoactive substances, have emerged as a significant public health and social stability threat due to their structural diversity, rapid iteration, and stronger ...

For example, multiple hemp shop operators in Austin have told the Chronic that customers who buy CBD oil for therapeutic use ...